United States · 
Who invested in Triumvira Immunologics?
Triumvira Immunologics's investors include B Capital and Northpond Ventures.
United States · Series A startup
Who invested in Triumvira Immunologics
One round we have observed, with the 2 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$45Mraised across 1 round since 2022, from 1 source
- Latest round
- Series A, $45MMar 2022
- Investors
- 2
The rounds
- Mar 2022
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Also claim to have backed them
This firm lists Triumvira Immunologics as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.
Quick answers about Triumvira Immunologics
How much has Triumvira Immunologics raised?
Triumvira Immunologics has raised $45M across 1 round since 2022.
When did Triumvira Immunologics last raise?
Triumvira Immunologics's most recent round was a Series A of $45M in Mar 2022.
What was Triumvira Immunologics's biggest round?
Its most recent round, $45M in Mar 2022, is also its largest on record.
Who backed Triumvira Immunologics first?
Triumvira Immunologics's first round on record, in Mar 2022, was backed by B Capital and Northpond Ventures.
What stage is Triumvira Immunologics at?
Triumvira Immunologics's latest named round is a Series A, in Mar 2022.
Where is Triumvira Immunologics based?
Triumvira Immunologics is based in the United States.
Companies like Triumvira Immunologics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.